Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
Mutat Res. 2009 Nov 2;670(1-2):88-95. doi: 10.1016/j.mrfmmm.2009.07.010. Epub 2009 Jul 30.
Patients who have had surgical bladder augmentation have an increased risk of bladder malignancy, though the mechanism for this increased risk is unknown. Hyperosmolal microenvironments such as the bladder may impair DNA damage signaling and repair; this effect may be more pronounced in tissues not normally exposed to such conditions. Comparing gastric and colon epithelial cell lines to transitional epithelial cell lines gradually adapted to an osmolality of 600 mOsm/kg with either sodium chloride or urea, cell lines of gastrointestinal origin were inhibited in their ability to activate ATM and downstream effectors of DNA damage signaling and repair such as p53, Nbs1, replication protein A (RPA), and gammaH2AX following the induction of DNA damage with etoposide. In contrast, bladder cell lines demonstrated a preserved ability to phosphorylate ATM and its effectors under conditions of hyperosmolal urea, and to a lesser extent with sodium chloride. The bladder cell lines' ability to respond to DNA damage under hyperosmolal conditions may be due in part to protective mechanisms such as the accumulation of intracellular organic osmolytes and the uroplakin-containing asymmetric unit membrane as found in transitional epithelial cells, but not in gastrointestinal cells. Failure of such protective adaptations in the tissues used for augmentation cystoplasties may place these tissues at increased risk for malignancy.
接受过手术性膀胱扩大术的患者膀胱癌风险增加,尽管这种风险增加的机制尚不清楚。高渗微环境(如膀胱)可能会损害 DNA 损伤信号和修复;这种影响在通常不暴露于此类条件的组织中可能更为明显。将胃和结肠上皮细胞系与逐渐适应渗透压为 600 mOsm/kg 的尿嘧啶或氯化钠的移行上皮细胞系进行比较,胃肠道来源的细胞系在其激活 ATM 及其下游 DNA 损伤信号和修复效应物(如 p53、Nbs1、复制蛋白 A(RPA)和γH2AX)的能力受到抑制,用依托泊苷诱导 DNA 损伤后。相比之下,在高渗尿素条件下,膀胱细胞系仍能磷酸化 ATM 及其效应物,而在氯化钠条件下则较少。膀胱细胞系在高渗条件下对 DNA 损伤做出反应的能力部分归因于保护性机制,如细胞内有机渗透物的积累和存在于移行上皮细胞中的含有尿嘧啶蛋白的不对称单位膜,但不存在于胃肠道细胞中。用于膀胱扩大术的组织中如果没有这种保护适应性,这些组织可能会增加恶性肿瘤的风险。